Search This Blog

Monday, May 27, 2019

Biomarin call 5/28 to update Phase 2 and 3 trials

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that management will host a conference call and webcast on Tuesday, May 28 at 8:00am ET to discuss program updates.
Conference Call and Webcast Information
Interested parties may access the live video webcast that will include audio and a slide presentation via the investor section of the BioMarin website, www.biomarin.com. A replay of the meeting will be archived on the site for one week.
For those who want access to the audio portion only, please use the dial-in information below:
U.S. / Canada Dial-in Number: (866) 502-9859
International Dial-in Number: (574) 990-1362
Conference ID: 2295086
Replay Dial-in Number: (855) 859-2056
Replay International Dial-in Number: (404) 537-3406
Conference ID: 2295086

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.